✦ LIBER ✦

Agrobacterium tumefaciens (or Agrobacterium radiobacter) septicemia in a patient with cervical carcinoma

✍ Scribed by Jane Meunier-Powell; Jose A. Sanabria; Jeffrey D. Axelrod

Book ID: 113294306
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 226 KB
Volume: 15
Category: Article
ISSN: 0196-4399
DOI: 10.1016/0196-4399(93)90059-v

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Teniposide in recurrent or advanced cerv

Teniposide in recurrent or advanced cervical carcinoma: A phase II trial in patients not previously treated with cytotoxic therapy

✍ Per Pfeiffer; Søren Cold; Kamma Bertelsen; Jytte Panduro; Erik Sandberg; Carsten 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 346 KB

A phase II study of sunitinib in patient

A phase II study of sunitinib in patients with locally advanced or metastatic cervical carcinoma: NCIC CTG Trial IND.184

✍ Helen J. Mackay; Anna Tinker; Eric Winquist; Gillian Thomas; Kenneth Swenerton; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Factors Predicting Response to Chemother

Factors Predicting Response to Chemotherapy and Survival in Patients with Metastatic or Recurrent Squamous Cell Cervical Carcinoma: A Multivariate Analysis

✍ Gerardo Zanetta; Walter Torri; Luca Bocciolone; Valeria Lucchini; Costantino Man 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 323 KB

Detection of cervical metastases with 11

Detection of cervical metastases with 11C-tyrosine pet in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with 18F-FDG PET

✍ Christiaan A. Krabbe; Gerreke van der Werff-Regelink; Jan Pruim; Jacqueline E. v 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Background. A disadvantage of 2‐[^18^F]fluoro‐2‐deoxy‐D‐glucose (^18^F‐FDG) positron emission tomography (PET) in head and neck cancer is that ^18^F‐FDG uptake is not specific to malignant tissue. To provide an alternative, radiolabeled amino acids such as L‐1‐[^11^C]‐tyrosine (^11^

208 POSTER A phase II study of sunitinib

208 POSTER A phase II study of sunitinib, an oral multi-targeted tyrosine kinase inhibitor, in patients with unresectable, locally advanced or metastatic cervical carcinoma: IND184

✍ H. Mackay; A. Tinker; E. Winquist; G. Thomas; J. Sederias; P. Ivy; E.A. Eisenhau 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Prognostic significance of parametrial e

Prognostic significance of parametrial extension in patients with cervical carcinoma stages IB, IIA, and IIB. A study of 628 cases treated by radical hysterectomy and lymphadenectomy with or without postoperative irradiation

✍ Takeo Inoue; Miwako Okumura 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB